Raloxifene, retinoids, and lavender: "me too" tamoxifen alternatives under study.
Ziegler
J
J
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy; D002986:Clinical Trials as Topic; D015507:Drugs, Investigational / Q000627:therapeutic use; D004965:Estrogen Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D027523:Lavandula; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D009822:Oils, Volatile / Q000009:adverse effects / Q000627:therapeutic use*; D010051:Ovarian Neoplasms / Q000188:drug therapy; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use*; D010938:Plant Oils; D010946:Plants, Medicinal; D011471:Prostatic Neoplasms / Q000188:drug therapy; D020849:Raloxifene Hydrochloride; D012176:Retinoids / Q000009:adverse effects / Q000627:therapeutic use*; D013629:Tamoxifen / Q000031:analogs & derivatives / Q000627:therapeutic use; D017312:Toremifene / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D015507:Drugs, Investigational; D004965:Estrogen Antagonists; D009822:Oils, Volatile; D010880:Piperidines; D010938:Plant Oils; D012176:Retinoids; D013629:Tamoxifen; C038345:droloxifene; C071362:idoxifene; D020849:Raloxifene Hydrochloride; D017312:Toremifene; C045718:lavender oil